Chesley Taft & Associates’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-4,833
Closed -$289K 299
2021
Q3
$289K Buy
4,833
+100
+2% +$6.29K 0.02% 275
2021
Q2
$294K Buy
4,733
+302
+7% +$20.1K 0.02% 273
2021
Q1
$285K Buy
4,431
+189
+4% +$12.3K 0.02% 269
2020
Q4
$279K Buy
+4,242
New +$250K 0.02% 261

Other funds holding EHC

Chesley Taft & Associates's EHC Position: Q4 2021 in Review

Chesley Taft & Associates sold out of Encompass Health (EHC) in Q4 2021, closing a stake of 4,833 shares — an estimated $289K sold.

Chesley Taft & Associates first reported a position in EHC in Q4 2020 and held it in 4 quarters. The position peaked at $294K in Q2 2021. 409 funds tracked by Wall St. Rank hold EHC as of Q4 2021.

  • Chesley Taft & Associates reported no remaining Encompass Health position as of Q4 2021 after selling out during the quarter.
  • Chesley Taft & Associates sold 4,833 Encompass Health shares in Q4 2021, an estimated $289K.
  • Chesley Taft & Associates first reported a position in Encompass Health in Q4 2020 and held it in 4 quarters.
  • Chesley Taft & Associates's Encompass Health position peaked at $294K in Q2 2021.
  • 409 funds tracked by Wall St. Rank held Encompass Health as of Q4 2021.

Based on Chesley Taft & Associates's 13F filing for Q4 2021, filed 5 Jan 2022.